Keywords: astrazeneca, sets, up, cpu, unit, china, following
AstraZeneca sets up CPU unit in China
Article | 10 September 2007
Following a $100.0 million R&D investment commitment in China last year (Marketletter 5, 2006), Anglo-Swedish drug major AstraZeneca has announced a strategic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
